🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The main purpose of the study is to determine the effects of 16 weeks of ad...
Status
Completed
Location
Albert Einstein College of Medicine West Campus Clinical Research Center
Start Date
2009-08
Trial ID
NCT01269047
Treatments Being Tested
The investigators propose a pilot study to test the novel hypothesis that E...
Status
Completed
Location
The University of Chicago
Start Date
2010-06-01
Trial ID
NCT01136798
The purpose of this study is to determine whether incretin-based drugs (use...
Status
Completed
Location
Lady Davis Institute for Medical Research, Jewish General Hospital
Start Date
2014-03
Trial ID
NCT02456428
Complex pathophysiological interactions among obesity, metabolic risk facto...
Status
Active Not Recruiting
Location
Ohio State University
Start Date
2025-09-15
Trial ID
NCT07188545
Treatments Being Tested
Exenatide is a licensed, safe and effective treatment for patients with Dia...
Status
Unknown
Location
National Hospital for Neurology and Neurosurgery
Start Date
2010-07
Trial ID
NCT01174810
Treatments Being Tested
Study D5553C0003 is a 28-week, randomized, double-blind, active-controlled,...
Status
Completed
Location
Research Site
Start Date
2014-09-04
Trial ID
NCT02229396
Treatments Being Tested
Study Design: Randomized, double-blind, placebo-controlled, escalating sing...
Status
Completed
Location
Multiple Locations
Start Date
2010-02
Trial ID
NCT01093729
The purpose of this study is to compare the benefits and risks of lixisenat...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2008-06
Trial ID
NCT00707031
Treatments Being Tested
Type 2 Diabetes (T2DM) is a life-long, chronic condition affecting an indiv...
Status
Completed
Location
Multiple Locations
Start Date
2011-12
Trial ID
NCT01602913
Treatments Being Tested